Silexion Therapeutics Corp (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.7200

-0.0300 (-4.00%)

Apr 21, 2025, 4:00 PM EDT - Market closed

Silexion Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2013	FY 2012
Period Ending	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Selling, General & Admin	0.24	0.17
Research & Development	1.12	0.79
Operating Expenses	1.36	0.95
Operating Income	-1.36	-0.95
Interest Expense	-0	-0
Interest & Investment Income	0	0.01
Currency Exchange Gain (Loss)	0	0.01
Pretax Income	-1.36	-0.94
Net Income	-1.36	-0.94
Net Income to Common	-1.36	-0.94
Shares Outstanding (Basic)	0	0
Shares Outstanding (Diluted)	0	0
Shares Change (YoY)	16.10%	-
EPS (Basic)	-81.80	-65.74
EPS (Diluted)	-81.80	-65.74
Free Cash Flow	-0.8	-0.91
Free Cash Flow Per Share	-48.23	-64.06
EBITDA	-1.36	-0.95
D&A For EBITDA	0	0
EBIT	-1.36	-0.95

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q